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Abstract
We have previously shown that the membrane-associat-
ed form of the GABA-synthesizing enzyme, glutamate
decarboxylase 65 (GAD65), is activated by synaptic vesi-
cle proton gradient-mediated protein phosphorylation.
We now report that the rate-limiting enzyme in dopa-
mine (DA) biosynthesis, tyrosine hydroxylase (TH), is
regulated similarly to GAD65. The membrane-associated
form of TH (MTH) was activated by conditions favoring
protein phosphorylation (e.g. ATP) and was inhibited by
phosphatase (e.g. calf intestine phosphatase). Further-
more, the ATP-mediated activation of MTH was abol-
ished by conditions that disrupted the proton gradient of
synaptic vesicles, e.g. the presence of carbonyl cyanide
m-chorophenylhydrazone, gramicidin, or the V-type
ATPase inhibitor (bafilomycin), but not the P-type
ATPase inhibitor (vanadate). Moreover, DA newly syn-
thesized from tyrosine by MTH and membrane-associat-
ed aromatic amino acid decarboxylase was taken up
preferentially rather than pre-existing DA. Therefore, the
previously proposed model showing close coupling be-
tween GABA synthesis and GABA packaging into synap-
tic vesicles by vesicular GABA transporters is also appli-
cable to the DA system. Hence, it is concluded that there
is a general coupling mechanism between neurotrans-
mitter synthesis and packaging of transmitter into synap-
tic vesicles.
Copyright © 2003 National Science Council, ROC and S. Karger AG, Basel
Introduction
Tyrosine hydroxylase (TH; EC 1.14.16.2) is the initial
enzyme in the biosynthesis of the catecholamines includ-
ing dopamine (DA), norepinephrine, and epinephrine.
TH catalyzes the hydroxylation of L-tyrosine to form 3,4-
dihydroxylphenylalanine (L-Dopa). It is a tetrahydropter-
idine (BH4)-dependent, iron-containing monooxygenase.
L-Dopa is further decarboxylated by aromatic L-amino
acid decarboxylase (AADC; EC 4.1.1.28) to form DA. In
the central nervous system, TH has been shown to exist in
two distinct forms, namely, soluble TH (STH) and mem-
brane-bound TH (MTH) [13, 14]. Alterations in the level
of DA induced by TH or AADC in the central nervous
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system have been implicated in neurodegenerative dis-
eases, including Parkinson’s disease [19], Huntington’s
disease [1], and schizophrenia [10].
Like other neurotransmitter-synthesizing enzymes,
such as L-glutamate decarboxylase (GAD) [2, 10], choline
acetyltransferase, cysteine sulfonic acid decarboxylase
[17], phosphorylation of TH plays an important role in
the regulation of TH activity and DA biosynthesis. Accu-
mulating evidence has shown that various protein kinases
catalyze the phosphorylation of TH at multiple serine
sites of the enzyme, e.g. Ser8, Ser19, Ser31, and Ser40 sites.
For instance, a proline-directed protein kinase isolated
from PC 12 cells has been shown to phosphorylate TH at
the Ser8 residue [18]. In rat pheochromocytoma cells and
brain synaptosomes, Ca2+/calmodulin-dependent protein
kinase II (CaMKII) has been reported to phosphorylate
TH at Ser19 [3, 9]. Two microtubule-associated extracellu-
lar signal-regulated kinases, ERK1 and ERK2, appear to
phosphorylate TH at Ser31 [8]. In addition, cyclic AMP
(cAMP)-dependent protein kinase (PKA) phosphorylates
TH at Ser40 [9]. In contrast to the large number of protein
kinases involved in the phosphorylation of TH, dephos-
phorylation of TH appears to be mediated by a single pro-
tein phosphatase identified as protein phosphatase 2A
[7].
Despite extensive studies on STH, little is known
about the regulation of brain MTH. We have previously
shown that the membrane-associated form of the Á-ami-
nobutyric acid (GABA) synthesizing enzyme, L-glutamic
acid decarboxylase (GAD65), is activated by synaptic vesi-
cle proton gradient-mediated protein phosphorylation
[10]. In this communication, we report that MTH is regu-
lated in a similar manner by a vesicular proton gradient
and protein phosphorylation.
In the GABAergic system, we have demonstrated that
vesicular GABA transporters (VGAT) preferentially
transport GABA newly synthesized from glutamate rather
than pre-existing GABA, and the presence of GAD inhibi-
tor decreases GAD activity as well as VGAT activity [12].
Further investigation reveals that VGAT forms a protein
complex with GAD65 on the synaptic vesicles, which
ensures an efficient coupling between GABA synthesis
and packaging into the synaptic vesicles [12]. Here, we
report a coupling mechanism in the DA system between
DA synthesis and its packaging into synaptic vesicles sim-
ilar to that demonstrated for the GABAergic system [12].
Materials and Methods
Materials 
Fresh porcine brains were obtained from a local slaughterhouse.
Ascorbic acid, adenosine diphosphate (ADP), adenosine monophos-
phate (AMP), adenosine triphosphate (ATP), bafilomycin A1, calf
intestinal phosphatase (CIP), carbonyl cyanide m-chorophenylhy-
drazone (CCCP), catalase, cAMP, gramicidin, mercaptoethanol,
phospho(enol)pyruvate, pyridoxal 5)-phosphate, pyruvate kinase, so-
dium fluoride (NaF), sodium orthovanadate, and BH4 were pur-
chased from Sigma (St. Louis, Mo.). L-[3,5-3H]tyrosine, [14C(U)]ty-
rosine, and [3,5-3H]DA were purchased from Amersham Biosciences
(Piscataway, N.J.).
Preparation of Synaptosomes
Unless otherwise specified, all procedures were carried out at
4°C. Substantia nigra, striatum, frontal cortex, and locus ceruleus
were dissected from fresh porcine brains. Crude synaptosomes were
prepared as described before [10]. Briefly, the dissected tissues were
homogenized in 0.32 M sucrose (w/v, 15 g/100 ml), and the homoge-
nate was centrifuged at 1,000 g for 10 min to remove nuclei and
debris (P1). The resulting supernatant liquid (S1) was collected and
further centrifuged at 12,000 g for 1 h. The pellet thus obtained (P2)
is referred to as the crude synaptosomes. They were divided into ali-
quots and stored at –70°C until used.
Preparation of STH and MTH
The frozen synaptosomal samples were thawed, suspended, and
sonicated in the standard TH buffer containing 50 mM Tris-maleate
(pH 6.8), 2 mM ß-mercaptoethanol, 50 mM sodium fluoride, and
0.1 mM EDTA. The homogenate was centrifuged at 100,000 g for
1 h. The resulting supernatant and pellet were used as the sources of
STH and MTH, respectively. The pellet was resuspended in the stan-
dard TH buffer. Both the supernatant and resuspension samples
were dialyzed extensively against dialysis buffer containing 50 mM
Tris-maleate (pH 6.8), 50 mM sodium fluoride, 0.1 mM EDTA, and
0.001% leupeptin.
Treatment with CIP
Treatment of STH and MTH samples with the CIP was con-
ducted as described previously [10] with some modifications. The
STH sample was applied to a CIP-conjugated agarose (714 units/ml)
column, which had been pre-equilibrated with 50 mM Tris-citrate
(pH 7.4) at 30°C. After application of the sample, the column was
stopped for 10 min to allow the STH sample to react with CIP. The
column was then washed with five column volumes of 25 mM Tris-
citrate buffer (pH 7.4), and the eluate collected was assayed for TH
activity. The MTH sample was incubated with 10 Ìl free CIP (1,100
units) at 30°C for 20 min. The reaction mixture was then centrifuged
at 100,000 g for 1 h to remove CIP. The pellet was resuspended in the
standard TH buffer and assayed for TH activity.
Determination of TH Activity
The activity of TH was measured based on the release of tritiated
water as described by Reinhard et al. [15]. Briefly, the reaction mix-
ture consisted of 150 mM Tris-maleate (pH 6.8), 500 ÌM BH4,
100 ÌM magnesium sulfate, 3,000 U of catalase, 5 mM ascorbic acid,
1.0 ÌCi L-[3,5-3H]tyrosine, and 100 Ìl sample in a final volume of
250 Ìl. The reaction was carried out at room temperature for 20 min
and was terminated by addition of 1 ml of 7.5% (w/v) charcoal slurry
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containing 1 M HCl. The samples were well mixed with charcoal and
left at room temperature for 30 min, followed by brief centrifugation
at 3,000 g for 5 min. An aliquot of 400 Ìl of supernatant was removed
for determination of radioactivity using a liquid scintillation counter.
Bafilomycin A1, CCCP, and gramicidin were dissolved in ethanol in
stock solutions; the ethanol concentration did not exceed 1% of the
incubation volume in the assay mixture. The controls containing the
same amount of ethanol were also included for each condition.
Preparation of Synaptic Vesicles
Briefly, crude synaptosomes obtained as described above were
resuspended and homogenized in 10 times the volume of cold dis-
tilled deionized water for 1 min. Osmolarity was restored by addition
of potassium chloride to a final concentration of 130 mM. Samples
were centrifuged for 20 min at 20,000 g to remove lysed synaptosom-
al membranes. The collected supernatant was then centrifuged for
1 h at 250,000 g. The resulting pellets containing synaptic vesicles
were suspended in KH buffer (90 mM KCl, 50 mM HEPES, pH 7.4,
at 30°C), and referred to as crude synaptic vesicles.
Vesicular Uptake Assay with [14C]DA Newly Synthesized from
[14C]Tyrosine and the Pre-Existing [3H]DA
The uptake assay was conducted as described by Floor et al. [5]
with modifications. Briefly, synaptic vesicles (1 mg of protein/ml)
were preincubated in KH buffer containing 250 Ìg/ml pyruvate
kinase at 30.0 B 0.01°C for 2 min in borosilicate glass test tubes.
Uptake was initiated by adding the following compounds in KH
buffer to final concentrations of 10 ÌM [14C(U)]tyrosine, 500 ÌM
BH4, 100 ÌM magnesium sulfate, 3,000 U of catalase, 5 mM ascorbic
acid, 0.2 mM pyridoxal 5)-phosphate at pH 7.2, 17 nM L-[3,5-
3H]DA, 2 mM ATP, 4.4 mM MgSO4, 12 mM phospho(enol)pyru-
vate, 1 mg/ml vesicle protein, and 100 Ìg/ml pyruvate kinase. For
[3H]DA and [14C]DA uptake measurements, a 50-Ìl aliquot of the
reaction mixture at different time intervals was applied to a nitrocel-
lulose filter (0.45 Ìm) and free [14C]tyrosine, [3H]DA and [14C]DA
were removed by vacuum-assisted filtration. The filter was washed
twice with 5 ml of ice-cold KH buffer within F5 s, and promptly
removed. Filters were dried and radioactivity trapped in filter was
counted using a liquid scintillation counter. Nonspecific uptake of
[3H]DA was measured in the presence of CCCP. Since dual isotopes
were applied, two separate channels were used for counting 14C and
3H activity.
Separation of DA from Tyrosine by an Anion Exchange Column
To verify that the content taken up into synaptic vesicles was
[14C]DA instead of [14C]tyrosine or [3H]DA, an anion-exchange resin
column was employed (Bio-Rad AG1X8 200–400 mesh chloride
form). The separation of standard tyrosine and DA was carried out as
described by Shibuya et al. [16] with modifications. Briefly, standard
tyrosine (45,000 dpm) or DA (15,000 dpm) in 500 Ìl of the KH buff-
er was applied to the column, followed by washing with water and
then 80 mM HCl. Tyrosine was not retained by the resin and flowed
through while DA was eluted out after application of HCl.
To establish the identity of the contents transported into synaptic
vesicles, aliquots of the extract from the synaptic vesicles were
applied to the column as described [12]. The column was first washed
with H2O until no radioactivity was detected, followed by elution
with 80 mM HCl. Eluates were collected at 1.5 ml per fraction, and
the radioactivity was counted in a scintillation counter. Two chan-
nels were used for counting 3H and 14C isotopes separately.
Fig. 1. Effect of ATP and protein phosphatase inhibitors on TH
activity. The STH and MTH samples were prepared as described
under ‘Materials and Methods’. The TH samples were incubated at
37°C for 30 min under the following conditions. Lane 1: standard
TH buffer; lane 2: standard TH buffer + 5 mM ATP; lane 3: standard
TH buffer + 5 mM ADP; lane 4: standard TH buffer + 5 mM AMP;
lane 5: standard TH buffer + 2 mM EGTA; lane 6: standard TH
buffer + phosphatase inhibitors (0.2 mM vanadate, 2 mM sodium
fluoride and 0.2 mM sodium pyrophosphate). Values represent
means and error bars represent the standard deviation of three deter-
minations.
Results
Effects of ATP and Phosphatase Inhibitors on TH
Activity
Both MTH and STH were activated under the condi-
tions favoring protein phosphorylation, e.g. in the pres-
ence of ATP or protein phosphatase inhibitors, as indi-
cated in figure 1. The activity of STH and MTH was
increased by ATP to 29 and 53%, respectively (fig. 1, lane
2). ADP and AMP at the same concentration as ATP had
no effect on the activity of both forms of TH (fig. 1, lanes
3 and 4). The presence of the divalent cation chelator, 2
mM EGTA, significantly attenuated both MTH and STH
activity (fig. 1, lane 5), suggesting a possible role of cal-
cium in TH regulation. Other phosphatase inhibitors, e.g.
0.2 mM vanadate, 2 mM sodium fluoride, and 0.2 mM
sodium pyrophosphate significantly inhibited the MTH
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Fig. 2. Effects of protein kinase activators on TH activity. The STH
and MTH samples were incubated under the following conditions.
Lane 1: standard TH buffer only; lane 2: TH buffer + ATP (5 mM );
lane 3: TH buffer + ATP (5 mM ) + cAMP (1 mM ); lane 4: TH buffer
+ ATP (5 mM ) + CaCl2 (1 mM ). Values represent means and error
bars represent the standard deviation of three determinations.
Fig. 3. Effects of phosphatase on TH activity. Both STH and MTH
samples were treated with CIP) as described in ‘Materials and Meth-
ods’. Lane 1: TH buffer as control; lane 2: TH buffer + 5 mM ATP;
lane 3: treatment with CIP; lane 4: same as lane 3, followed by addi-
tion of 5 mM ATP. Data are expressed as the mean B the standard
deviation. Values represent means and error bars represent the stan-
dard deviation of three determinations.
activity, while STH activity was slightly increased (fig. 1,
lane 6).
Effects of Protein Kinase Activators on TH Activity
As shown in figure 2, PKA activator, cAMP, great-
ly enhanced the ATP activation of both forms of TH
(lane 3). However, Ca2+, an activator for both PKC and
CaMKII, only slightly stimulated the ATP activation of
both forms of TH (fig. 2, lane 4).
Effects of Phosphatase Treatment on TH Activity
The treatment of nonspecific phosphatase, CIP, re-
duced TH activity as indicated in figure 3. The activity of
STH and MTH was reduced by CIP to 18 and 22%,
respectively (lane 3). The activity of CIP-treated STH and
MTH was increased substantially by 40 and 78%, respec-
tively, in the presence of 5 mM ATP (lane 4).
Dependence of ATP Activation of MTH on the Proton
Gradient Across the Synaptic Vesicles
When the proton gradient across synaptic vesicles
was disrupted by the protonophore uncoupler, CCCP
(100 ÌM), or ionophore, gramacidin (10 ÌM), the ATP
activation of MTH was almost completely abolished, as
shown in figure 4 (lanes 4 and 6). In addition, bafilomycin
A1, a specific V-type ATPase inhibitor, at the concentra-
tion of 6 ÌM also abolished ATP activation of MTH (lane
8). However, vanadate, a P-type ATPase inhibitor, had no
effect on ATP activation of MTH (lane 10).
Preferential Uptake of the Newly Synthesized
Dopamine from Tyrosine Rather than from the
Pre-Existing Dopamine in Cytosolic Pools
To illustrate that DA vesicles preferentially take up
newly synthesized DA, dual radioactive-labeled [3H]DA
and [14C]tyrosine were used as pre-existing DA pool and
newly synthesized DA, respectively. 10 ÌM (46 ÌCi) of
U-[14C]tyrosine and 17 nM (0.5 ÌCi) of [3H]DA were
included in 250 Ìl of uptake reaction mixture. Based on
the TH activity assays under the same conditions, only
0.16% of tyrosine was converted to DA. This would give a
concentration of newly synthesized [14C]DA in the uptake
mixture around 17 nM, which is the concentration used
for the pre-existing [3H]DA. As indicated in figure 5, the
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Fig. 4. Dependence of ATP activation of
MTH on the proton gradient across synaptic
vesicles. Effects of various proton gradient
uncouplers or inhibitors on TH activity
alone or on ATP activation of TH were stud-
ied as described in ‘Materials and Methods’.
CCCP and gramicidin were dissolved in eth-
anol in stock solution. The controls con-
tained ethanol in concentrations not to ex-
ceed 1% of the incubation volume. Lane 1:
control; lane 2: ATP alone (5 mM ); lane 3:
CCCP alone (100 ÌM ); lane 4: ATP (5 mM )
+ CCCP (100 ÌM ); lane 5: gramicidin alone
(10 ÌM ); lane 6: ATP (5 mM ) + gramicidin
(10 ÌM ); lane 7: bafilomycin alone (6 ÌM );
lane 8: ATP (5 mM ) + bafilomycin (6 ÌM );
lane 9: vanadate alone (200 ÌM ); lane 10:
ATP (5 mM ) + vanadate (200 ÌM ). Values
represent means and error bars represent the
standard deviation of three determinations.
Fig. 5. A comparison of DA uptake from
newly synthesized DA versus pre-existing
DA. [14C]tyrosine was used to generate new-
ly synthesized [14C]DA in the uptake assay
system, while [3H]DA was included as pre-
existing DA in uptake experiments. Uptake
of DA is expressed as picomoles/milligram
protein. DA uptake in the presence of CCCP
was used as nonspecific uptake and was sub-
tracted from total uptake. Values represent
means and error bars represent the standard
deviation of three determinations.
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Fig. 6. Separation of tyrosine and DA on an
anion exchange column. a Elution pattern of
standard tyrosine (45,000 dpm) and dopa-
mine (15,000 dpm) on an anion exchange
column. Tyrosine was eluted out when
washed with H2O (first peak), while DA was
eluted later with 80 mM HCl as indicated in
the second peak. b Elution pattern of the
content extracted from synaptic vesicles as
described in ‘Materials and Methods’. The
first peak corresponding to tyrosine is the
nonspecifically absorbed tyrosine, the sec-
ond large peak corresponding to the stan-
dard DA is newly synthesized [14C]DA taken
up by DA synaptic vesicles. The small peak
at the same position as [14C]DA is [3H]DA
taken up from the pre-existing [3H]DA pool.
newly synthesized [14C]DA, but not the pre-existing
[3H]DA, was preferentially taken up by vesicular DA
transporter and reached saturation to about 160 pmol/mg
protein, whereas the uptake of pre-existing [3H]DA was
only about 400 pmol/mg/ protein.
Identification of Uptake Contents as Newly
Synthesized DA from Tyrosine
The majority of 14C-labeled content transported into
the SVs was identified as DA (fig. 6b) since it has the same
elution pattern as standard DA, as shown in figure 6a. The
small amount of [14C]tyrosine in the synaptic vesicle was
probably due to the contamination of remaining [14C]ty-
rosine on the filter paper. The small portion of [3H]DA
detected in the synaptic vesicles likely resulted from the
initial uptake by vesicular monoamine transporter when
the amount of newly synthesized DA was low. These
results suggest that the content taken up by dopaminergic
synaptic vesicles was not the substrate, [14C]tyrosine, but
newly synthesized [14C]DA from [14C]tyrosine by synap-
tic vesicle-associated TH and AADC.
Discussion
Two methods are commonly used for assaying TH
activity. The first is based on the release of [3H]H2O from
[3H]tyrosine catalyzed by TH. The second is a coupling
assay based on the TH-catalyzed conversion of L-1-14C
tyrosine to L-1-14C-Dopa, followed by decarboxylation of
[14C]DOPA by AADC. However, most studies of TH
reported in the literature were conducted using the cou-
pled methods. This coupled hydroxylation-decarboxyla-
tion method is only useful if the conditions tested only
affect TH but not decarboxylase. Studies on the relation-
ship between phosphorylation of AADC and its activa-
tion are less well investigated than that of TH. Only a few
reports demonstrate that the AADC activity increases
when it is phosphorylated by PKA [4] or PKC [20] in
vivo. However, a lack of regulation of the AADC by PKA
or PKC in vitro has also been reported [21]. In the present
study, we used the method measuring the TH activity
directly to avoid the complication of the coupled methods
as mentioned above.
Although TH has been extensively studied, most stud-
ies have been done only with STH, but not MTH. Here,
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Fig. 7. A proposed model linking neuronal stimulation to activation
of TH and a functional coupling between dopamine synthesis and
packaging into synaptic vesicles.
we report that both MTH and STH are activated by ATP
and inactivated by CIP, suggesting that TH is regulated by
protein phosphorylation. Although MTH is similar to
STH in that both forms of TH are activated by phosphor-
ylation and inhibited by dephosphorylation, there is one
major difference between MTH and STH, namely, activa-
tion of MTH but not STH by ATP appears to be mediated
by the proton gradient which is maintained by V-type
ATPase. This notion is supported by the observations that
ATP activation of MTH was abolished under conditions
that disrupt the proton gradient of synaptic vesicles, such
as in the presence of CCCP, gramicidin, and bafilomycin
A1.
In regard to the nature of TH phosphorylation and its
effect on TH activity, there is a consensus that phosphory-
lation of Ser40 increases TH activity [7]. Phosphorylation
of Ser19 has also been reported to increase TH activity in
the presence of an activator, Ca2+. However, phosphoryla-
tion of Ser31 appears to have no effect on STH activity.
Thus, STH is regulated by multiple kinases. In the present
study, we have shown that MTH, like STH, is likely to be
regulated by multiple kinases such as PKA and CaMKII
since the activators of these kinases, e.g., cAMP and Ca2+,
activated both forms of TH activity. However, further
studies are needed to elucidate the relationship between
phosphorylation and TH activity.
The newly synthesized DA from tyrosine was preferen-
tially taken up by VMAT-2 over the pre-existing DA pool,
suggesting that synaptic vesicle MTH is responsible for
DA synthesis and transport into synaptic vesicles. It is
reasonable to speculate, based on the uptake data, that
AADC, the second enzyme involved in DA synthesis, is
also possibly synaptic vesicle-associated. Whether there is
a protein complex of MTH and AADC associated with
synaptic vesicle warrants further investigation.
Recently, we have shown that the synthesis of GABA
in mammalian CNS is regulated through proton gradient-
dependent protein phosphorylation [10]. We further re-
ported that there is a functional and structural coupling
between GABA synthesis and GABA packaging into syn-
aptic vesicles [10, 12]. Here we report similar findings for
the DA system. We have shown that the synthesis of DA
by TH is also regulated by protein phosphorylation which
is dependent upon the proton gradient of synaptic vesi-
cles. Therefore, we propose that a general mechanism
linking the neuronal stimulation to the enhanced neuro-
transmitter synthesis and transport into synaptic vesicles
is present in the GABAergic as well as the dopaminergic
systems, as illustrated below (fig. 7). When neurons are
under depolarizing conditions, Ca2+ ions enter the nerve
terminal through voltage gated-calcium channels, result-
ing in vesicular release of dopamine by a kiss and run
mechanism [6] or exocytosis (step 1). The proton gradient
is then restored on synaptic vesicles through V-type
ATPase activity (step 2). MTH is then activated by proton
gradient-dependent protein phosphorylation mediated by
synaptic vesicle-associated protein kinase, which is acti-
vated by influx of Ca2+ from step 1 (step 3). L-Tyrosine is
converted to L-Dopa (step 4). Another DA synthesizing
enzyme, AADC, has been shown to be phosphorylated
and activated in the presence of PKA [4] and PKC activa-
tor [21]. Hence, AADC is likely to be activated also by
proton gradient-dependent protein phosphorylation by
synaptic vesicle-associated protein kinases (step 5).
Therefore, more DA is generated due to increased activity
of both TH and AADC. Newly synthesized DA is then
transported into synaptic vesicles by vesicular mono-
amine transporter (VMAT) (step 6). These refilled vesi-
cles are ready to release DA upon arrival of another action
potential. Furthermore, the influx of Ca2+ into synaptic
vesicles also activates the Ca2+-dependent protein kinase
(e.g. CaMKII), resulting in phosphorylation and activa-
tion of STH. The newly synthesized DA by STH can also
be transported to the synaptic vesicles by VMAT, al-
though at a much slower rate, to provide basal activity.
The model proposed here for the DA system differs
from the one we previously proposed for the GABAergic
system in that there are two enzymes involved in the syn-
thesis of DA, namely, TH and AADC, whereas there is
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only one enzyme, namely, GAD, involved in GABA syn-
thesis. Hence, for the DA model, we propose a structural
coupling between vesicular DA transporter and both TH
and AADC, while for the GABA model, vesicular GABA
transporter is coupled to GAD only.
In summary, TH is regulated presumably at multiple
sites by different protein kinases for both the soluble and
membrane-bound forms. In addition, ATP activation of
MTH is dependent on the integrity of the proton gradient
of synaptic vesicles. Furthermore, the model we proposed
recently for the GABAergic system showing functional
and structural coupling between neurotransmitter synthe-
sis and its packaging into synaptic vesicles appears to be a
general mechanism applicable to the DA system. The
nature of molecular anchoring of MTH to synaptic vesi-
cles and coupling to the vesicular dopamine transporter
requires further investigation.
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